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Abstract 
This review aims to determine the metabolic effect of hyperuricemia in pregnant woman, especially those with 
gestational diabetes mellitus (GDM). In women, the serum uric acid level is lower compared to men of similar 
age. The value is related to higher estrogen concentration to increase uric acid clearance. Hyperuricemia 
already established as independent risk factors for metabolic syndrome and cardiovascular disease (CVD) as 
well as type 2 Diabetes Mellitus (DM). Asymptomatic hyperuricemia in non-pregnant adult women will 
increase insulin resistance due to oxidative stress, and production of inflammatory cytokine (tumor necrosis 
factor-), which inevitably increases blood sugar level. Uric acid level and serum creatinine is lower in normal 
pregnancy due to increased renal clearance and the uricosuric effect of estrogen. Hyperuricemia is one of the 
contributing factors associated with insulin resistance among pregnancy instead direct effect of placental 
hormones. Earlier in the first trimester of pregnancy, the risk for GDM is increased. However, the causal effect 
of uric acid levels on DM still requires further study . 
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Hiperurisemia pada Kehamilan dan Diabetes Gestasional 
 
Abstrak 
Tulisan ini bertujuan untuk mengetahui efek metabolik hiperurisemia pada wanita hamil, khususnya pada 
populasi gestational diabetes mellitus (GDM). Kadar asam urat serum pada wanita lebih rendah jika 
dibandingkan dengan pria dengan usia yang sama. Hal ini terkait dengan konsentrasi hormon estrogen yang 
lebih tinggi yang dapat meningkatkan bersihan asam urat. Seperti yang diketahui, hiperurisemia merupakan 
faktor risiko independen sindrom metabolik dan penyakit kardiovaskular (CVD) maupun diabetes mellitus 
(DM). Hiperurisemia asimptomatik pada orang dewasa yang tidak hamil akan meningkatkan resistensi insulin 
akibat peningkatan stres oksidatif, dan produksi sitokin inflamasi (tumor necrosis factor-), yang pada 
akhirnya meningkatkan kadar gula darah. Kadar asam urat dan kreatinin serum lebih rendah pada kehamilan 
normal karena terjadi peningkatan pembersihan ginjal dan efek urikosurik dari hormon estrogen. 
Hiperurisemia merupakan salah satu faktor yang berkorelasi dengan terjadinya resistensi insulin selama 
kehamilan, alih alih efek langsung dari hormon plasenta. Pada awal trimester pertama kehamilan, risiko 
GDM meningkat. Meskipun demikian, efek kausal dari kadar asam urat pada DM membutuhkan penelitian 
lebih lanjut. 
 
Kata Kunci: Hiperurisemia, Diabetes Gestasional, diabetes mellitus tipe 2 
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Introduction 
 
Hyperuricemia in Asian populations is 
currently increasing, most likely related with the 
nature of diet and environment.1 Elevated serum 
uric acid can be caused by either an increase in uric 
acid  production, or impaired renal excretion, 
and/or a combination of both factors.2 
Oversaturation of serum uric acid, approximately 
at > 6.8 mg/dL, can manifests from asymptomatic 
hyperuricemia to chronic monosodium urate 
(MSU) crystal deposition in several target organs, 
mainly the musculoskeletal tissue (cartilages, 
tendons, soft tissue, bony process, and ligaments), 
and kidneys.3  
In women, the serum uric acid level is 
lower compared to in men of a similar age (normal 
value: < 6.0 mg/dL).4 On the other hand, the 
concentration of uric acid remains stable at 4.0 ± 
2.0 mg/dL until menopause.4 This lower value is 
known to be related possibly with higher estrogen 
concentrations that leads to increased uric acid 
clearance.4,5 However, even in low-risk pregnancy 
(primigravida and no concurrent hypertension or 
other comorbidities), a study by Jayanthi et al 
reported that the incidence of hyperuricemia was 
found around 47% of patients.4 
In non-pregnant populations, chronic 
inflammatory event caused by asymptomatic 
hyperuricemia associates with several clinical 
consequences.5 Some findings already established 
the correlation of hyperuricemia as independent 
risk factors for non-emerging diseases especially 
metabolic syndrome and cardiovascular disease 
(CVD).6 The increment of 1 mg/dl serum uric acid 
will notably increase the risk of diabetes mellitus 
(DM) type 2 to 17%.7 However, the postulates of 
hyperuricemia causing either hyperglycemia or 
hyperinsulinemia in both direction remain 
controversies.8 A meta-analysis done in an Asian 
population by Choi et al reported that 
hyperuricemia was a strong independent predictor 
of the incidence of new-onset  type 2 DM (HR: 
1.78, 95% CI: 1.12 to 2.8) after 5 years follow up.9 
The risk is especially increased in females, old age 
(≥ 55 years), mild obesity (body mass index (BMI) 
24-30 kg/m2), coronary artery disease (CAD), 
metabolic syndrome, smoking, alcohol intake, in 
patients without hypertension, hyperlipidemia, and 
stroke.9 
Yet some reports also reported an 
association between hyperuricemia as a risk factor 
in increasing insulin resistance, and gestational 
diabetes. This review aims to determine the 
metabolic effect of hyperuricemia in pregnant 
women, especially women with GDM. 
 
Uric Acid Metabolism in Non-Pregnant Adult 
 
 Uric acid production and metabolism 
depend on various factors that regulate hepatic 
production, as well as renal and gut excretion of 
uric acid.10 Serum uric acid pool may result from 
the end product of an exogenous pool of purine and 
endogenous purine metabolism.10 The purine pool 
varies significantly with diet, especially animal 
protein.10 High fructose diet and high sodium 
intake are also contributory factors in the increase 
of uric acid level and production.8 On the other 
hand, endogenous production uric acid is mainly 
from the liver, intestines and other tissues like 
muscles, kidneys and vascular endothelium.10 Up 
to know, there are 28 single-nucleotide 
polymorphisms (SNPs) known to affect uric acid 
level.11 The gene encodes SLC2A9 that also 
encodes glucose transporter 9 (GLUT9) and ATP-
binding cassette G2 (ABCG2) mainly influential to 
hyperuricemia.11 The variation in SLC2A9 may be 
responsible for 3.5% variation, particularly in 
women.11 On the other hand, non-synonymous 
SNP in ABCD decreases urate efflux by 53%.11 
 Asymptomatic increase of serum uric acid 
metabolism may affect several target organs in 
addition to the joints and kidneys. The generation 
of uric acid from hypoxanthine and xanthine by 
xanthine oxidase  (XO) enzyme pathway may 
induce the production of reactive oxygen species 
(ROS) which contributory to cardiac dysfunction 
to failing myocardium.1 The study by Barbieri, et. 
al. concludes a strong association between higher 
uric acid concentration and the prevalence of 
severe  coronary artery disease (CAD) particularly 
in women.12  
 Asymptomatic hyperuricemia in non-
pregnant adults increases insulin resistance due to 
oxidative stress and production of inflammatory 
cytokine (tumor necrosis factor-), which 
ultimately increases blood sugar level.15,21 For 
decades, the evidence remains debatable in 
assuming that hyperuricemia as the consequences 
of insulin resistance or precursor. However, in a 
recent study, the hyperuricemia is a predictor for 
insulin resistance, and independent risk factor to 
develop  type 2 DM within 10 years especially in 
women.8,13,14  
 
Uric Acid Metabolism, Hyperuricemia, and 
Insulin Resistance During Pregnancy 
 
The uric acid level and serum creatinine 
should be lower in normal pregnancy due to 
increased renal clearance and the uricosuric effect 
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of estrogen.15 The elevation of serum uric acid level 
has been associated with several adverse 
pregnancy outcomes. This may result in the 
collaborative addition of oxidative stress, renal 
dysfunction, tissue injury, and cardiovascular 
disease, which commonly seen in severe 
preeclampsia.16 However, even maternal 
hyperuricemia in normotensive women was  
associated with preterm birth (p=0.0001), small for 
gestational age (SGA) delivery (p=0.02), 
development of neonatal intraventricular 
hemorrhage (IVH) (p=0.007), increased likelihood 
of neonatal NICU admission (p=0.002) and lower 
1- and 5- minute Apgar scores (p=0.004).17 Several 
mechanisms have been proposed suggested about 
this vicious effect of uric acid on pregnancy 
outcomes. One study showed inhibition of 
placental system amino acid transport with uric 
acid treatment, as a result of uric acid-induced 
stimulation of intracellular redox signaling 
cascades, which ultimately causes intrauterine 
growth restriction.18 Another study proposed to 
elicit a concentration-dependent attenuation of 
trophoblast invasion and integration into a uterine 
microvascular endothelial cell monolayer; 
therefore, uric acid is able to induce the formation 
of a dysfunctional placenta.19 These studies 
demonstrate that newborns of mothers with 
elevated serum uric acid levels are at increased risk 
for perinatal distress.19 
The development of insulin resistance 
related to hyperuricemia in pregnancy most likely 
has the same mechanism as in non-pregnant adult 
women. There are two proposed hypotheses for 
hyperuricemia which aggravate insulin resistance 
and alter glucose metabolism: via the inhibition of 
nitric oxide (NO) release from endothelial cells 
(which normally mediate glucose uptake to skeletal 
muscle), or from adipocytic secretion of uric acid, 
which mediates inflammatory cytokines and 
induces oxidative changes in the adipocytes.11 
In physiological conditions, insulin 
resistance increases during mid-pregnancy and 
normalize upon delivery.20 In 24-28 weeks of 
gestation, several metabolic changes take place to 
trigger insulin resistance, which was determined 
using homeostatic model for insulin resistance 
(HOMA-IR), instead direct effect of placental 
hormones (human placental lactogen, prolactin, 
progesterone, and placental leptins).20 Other 
contributory factors associated with insulin 
resistance among pregnancy are pre-conceptional 
obesity, the presence of diabetogenic hormones 
(cortisol, tumor necrosis factors-, and 
interleukin’s) and hyperuricemia.15,21 Boaz et al 
reported that pregnancy with hyperuricemia and 
gestational hypertension but not preeclampsia 
strongly correlated with increased insulin 
resistance (45 ± 31.2% vs. 79.7 ± 33%; p = 
0.018).15 However maladaptive process of -cells 
or to higher insulin demands may result in GDM.20 
 
Hyperuricemia, Gestational Diabetes and 
Pregnancy 
  
 From our literature review hyperuricemia 
already established as an independent risk factor 
for gestational diabetes in early pregnancy. Earlier 
in the first trimester of pregnancy, a study by 
Laughton et al found that the risk for GDM 
increases 3.25-fold in patients with uric acid level 
≥ 3.6 mg/dL (95% CI: 1.35-7.83). They also found 
that hyperuricemia risk for GDM is concentration-
dependent (p=0.003), and independent of BMI.14 A 
study by Plescakova et al found that pregestational 
BMI, early pregnancy level of uric acid, and 
xanthine levels are associated with GDM.11 Similar 
results have also been discovered in Asian 
populations but with different cut off value (see 
Table 1). 
 
Table 1. Summary of Studies on The Association between Hyperuricemia with GDM in Asian Populations 
 
No Author Population Methods Result 
1. Fawzy et al22 273 pregnant first 
trimester patients with 
low risk for type 2 DM 
Prospective 
observational study 
Higher risk for developing GDM in patients 
with uric acid level > 3.1 mg/dL (sensitivity: 
77.8% and specificity: 66.5%) 
2. Chauhan et 
al23 
300 pregnant first 
trimester patients with 
low risk for type 2 DM 
Prospective 
observational study 
83% patients with uric acid level > 5 mg/dL 
developed GDM (sensitivity 62.5% and 
specificity 99%) 
3 Ganta et al 24 312 pregnant first 
trimester patients with 
low risk for type 2 DM 
Prospective 
observational study 
Higher risk for developing GDM in patients 
with uric acid level > 3.5 mg/dL (mean uric 
acid level in GDM and non-GDM group 
3.59±1.10, p=0.001) 
4 El-Gharib et 
at 25 
250 pregnant first 
trimester patients with 
Prospective 
observational study 
Higher risk for developing GDM in patients 
with uric acid level > 4 mg/dL (sensitivity 
44.7% and specificity 89.6%) 
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high risk for type 2 
DM 
5 Nader et al 26 80 pregnant first 
trimester patients with 
low risk for type 2 DM 
Prospective 
observational study 
Higher risk for developing GDM in patients 
with uric acid level > 3.11 mg/dL (sensitivity: 
100% and specificity: 74.2%) 
6 Rasika et al27 70 pregnant first 
trimester patients with 
low risk for type 2 DM 
Prospective 
observational study 
Uric acid in <15 weeks gestation  more 
significantly associated with risk of 
development GDM compared to 24 and 24 
week gestation (Pearson’s correlation = 
0.735) 
 
From the different phenomena described in 
mid-pregnancy (second trimester), and the post-
partum period it ccan be concluded that there is a 
non-significant association between hyperuricemia 
with GDM risk. However, contrary to that of uric 
acid, the negative outcomes of xanthine level in 
postpartum is associated with gestational age at 
delivery.11 However, the effect of uric acid levels 
on diabetes mellitus (DM) required further study 
because only 5.9% of women developed  type 2 
DM or other types of DM after 1 year 
observation.11  
 
Conclusion 
 
The development of insulin resistance by 
hyperuricemia in pregnancy has the same 
mechanism as non-pregnant adults. Hyperuricemia 
increases insulin resistance via inhibition of NO 
release from endothelial cells, and the other is from 
adipocytes secretion of uric acid that precisely 
mediates inflammatory cytokines and induces 
oxidative changes in adipocytes. However, the 
effect of uric acid levels on diabetes mellitus 
requires further study because only 5.9 % of 
women developed type 2 DM or other types of DM. 
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